2014 - Transplant Infectious Disease Conference


This page contains exclusive content for the member of the following sections: TTS, TID. Log in to view.

Pesky Pathogens: Viruses

1.3 - HCV management and use of + donors into + recipients, esp with novel emerging therapies

Presenter: Maria-Carlotta, Londono, , Spain
Authors: Maria-Carlotta Londono

Hepatitis C (HCV) recurrence after liver transplantation (LT) is universal. The natural history of the recurrence is characterized by rapid fibrosis progression with 20-30% of the patients developing cirrhosis within 5 years of LT . Graft and patient survival are significantly lower in HCV-infected liver transplant recipients as compared to individuals who undergo LT for other indications. Therefore eradication of the virus is an important goal.

Treatment of HCV infection in the peri-transplant setting can be performed in two different situations. First, in patients awaiting LT in order to prevent HCV infection of the graft, and second, in patients with HCV recurrence after LT in whom HCV-related graft damage has already occurred. 

In the recent years there has been a major step forward in the treatment of hepatitis C with the development of new DAA. Results of the studies presented recently prove that hepatitis C can be cured both pre and post liver transplantation in a significant number of patients with minor adverse event. It is probable that hepatitis C will not continued be a major problem of transplant programs.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada